I wrote yesterday that I was on the fence with regards to retaining the AppLovin position. In a sense I still am but yesterday’s bounce led to a different decision. It has been a ghastly trade but I feel it better to move on than determine just how the potential of the company’s non-gamer introduction…

To access this post, you must subscribe.

Read More

I have recommended Cerebras shares and the Ticker Target high growth portfolio currently has a 3.87% weight in the shares. The shares have dropped by almost 18% so far this week. The drop is a function of a report from a publication called SemiAnalysis that OpenAI is using some Nvidia chips to power the Ultrafast…

To access this post, you must subscribe.

Read More

Zolak/iStock via Getty Images April is often said to be the cruelest month; In the case of Credo, September has been! The AI boom has spawned many investment opportunities. Some adjacencies such as power supplies and physical data center structures seem obvious. Cables… which is what Credo (CRDO) has been best known for…not so much.…

To access this post, you must subscribe.

Read More

We made some changes in the high growth portfolio this morning. After thinking about what to do with the Tempus position, we wound up selling the shares. The shares have nearly doubled in the last 6 months and have risen by more than 30% in last 30 days. There was a specific reason for that;…

To access this post, you must subscribe.

Read More

We had planned to add to the Nebius position this week but it never reached our limit price. That said, Bloom Energy shares fell noticeably because of continued controversy with regards to the Dona Ana, NM data center that its technology is meant to power. Today, Oracle invoked Force Majeure, sending a letter to the…

To access this post, you must subscribe.

Read More

JHVEPhoto/iStock Editorial via Getty Images Netskope’s market share is rising now; how long before that is reflected in its valuation Patience is a virtue in many things, investing amongst them, but sometimes when companies report strong quarters but the share price doesn’t follow suit, maintaining patience can be a bit of stretch. I wrote about…

To access this post, you must subscribe.

Read More

This morning Axon announced that it was selling $1 billion of 0% convertibles. The conversion price has not been announced. My guess is that it will be at a 50% premium.  There is lots of demand for convertible offerings of high growth technology vendors and indeed there are funds who only invest in such converts. …

To access this post, you must subscribe.

Read More

A somber day for me-I lost one of my favorite clients this day-a mother of 3 small children. I still have a hard time understanding a world that lets that happen. The high growth portfolio made some portfolio changes this morning at the opening. A lot of times I read headlines that are either not…

To access this post, you must subscribe.

Read More

atakan/iStock via Getty Images Zeta: An enterprise marketing cloud worth knowing Adtech has been a difficult software vertical in which to invest so far in 2026. There have been many investment casualties ranging from The Trade Desk (TTD) to AppLovin (APP)  to Hubspot (HUBS). It isn’t that digital marketing growth has stalled-Overall digital market spending…

To access this post, you must subscribe.

Read More

The high growth portfolio added to positions in Netskope and Bloom Energy earlier today. Netskope reported last evening. The shares, which are up modestly, did not, in my opinion, reflect the strength of what was actually reported. In particular, these results, which included a record net new ARR of $54 million, indicate that Netskope is…

To access this post, you must subscribe.

Read More